Dr. Robert (Rob) Randelman, Ph.D joins Dr. Benedict S Maniscalco as a member of its’ Senior Advisory Board effective June 15, 2017. This follows the acquisition of HubCentrix and the CyberCare Health Network Chronic Care Management System. Both companies operate as HealthDatix, Inc.

The addition of Dr. Randelman to iGambit’s Advisory Board brings on a senior executive with strong technical, management and international experience with a record of growth in technically-based businesses. As a company Chairman and CEO/President he drove strategy in M&A, IP Licensing, market expansion and technology development. Efforts that resulted in dynamic growth with P&L responsibility for a company with over $140 million annual revenue, and over 500 employees in 7 countries. He has been successful in developing international markets in Latin America, Europe and China.


Currently, Dr. Randelman is Chief Executive Officer of Trident Science, LLC, a privately held scientific products and consulting company. Prior to his current role, he was the  a Divisional Chief Executive and Executive Board Member for Halma, PLC. His career has spanned global executive roles in sales, marketing, operations and technology with Ocean Optics, Inc, VeriFone, Inc., Hewlett-Packard Corp and Exxon-Mobil Corp.


Dr. Randelman earned a  BS degree in Chemistry/Physics from Ursinus College, as well as Masters and Ph.D degrees in Chemical Engineering from Lehigh University.     


Regarding publications and Patents, Robert’s credits include: over 20 papers and publications in diverse areas of science, technology and technology management; also, one patent and 12 registered processes, spanning a wide range of technologies.